There’s a scientific revolution taking place.
Our investments in the National Institutes of Health (NIH) have helped wipe out diseases that killed our grandparents, and have led us to the brink of new discoveries that will free future generations from the diseases that we still suffer and fear.
The mapping of the human genome and advances in our understanding of the way life works have led us into an exciting new era of discovery, unique in scientific history.
Scientists now have the opportunity to beat back disease using new knowledge of biological structures and functions. They are no longer describing an illness’ symptoms, throwing everything they have at it, and watching to see what works.
Instead, in important areas, they are using the knowledge gained through more than 40 years of arduous study to zero in strategically on a disease, its triggers and crucial moments of development. Using discoveries and new technologies made in just the last decade, they can now understand the molecular drivers of disease and affect them.
And since the large majority of federal funding to the NIH goes directly to researchers at America’s major universities and private research institutions, NIH funding also creates jobs, spurs the growth of critical pharmaceutical and biotech industries, and in the long term, reduces health care costs thanks to healthier, longer life.
At this critical moment in our nation’s history, sustained investments in biosciences through the only federal agency specifically designed for this purpose — the NIH — makes more sense than ever.
That’s why 20 of the nation’s leading scientific research institutions and industries, and health and patient advocates, have united behind a single purpose: to call upon the United States to make a new commitment to funding the NIH.
We’re seeking steady growth in the NIH budget over the long term, because the fruits of science are a necessity, not a luxury, as much in hard times as in good. And our scientific opportunities have never been greater.
We call our efforts United for Medical Research (UMR). We’re launching a multi-year advocacy and education campaign to seek the NIH funding necessary for delivering on the promise of this historic moment in biomedical science.
2016 UMR Board and Officers
David Pugach, American Cancer Society Cancer Action Network – President
Tim Fenton, Thermo Fisher Scientific – Treasurer
Lizbet Boroughs, Association of American Universities – Secretary
Margaret Anderson, FasterCures
Jennifer Grodsky, Boston University